Læknablaðið - 15.09.1992, Side 14

276
LÆKNABLAÐIÐ
Svenska Lakarasallskapets Riksstamma 1988;
Sammanfattningar, 185-6.
23. Castelli WP. The triglyceride issue: A view from
Framingham. Am Heart J 1986; 122: 432-7.
24. Sigurðsson G, Baldursdóttir Á, Sigvaldason H,
Agnarsson U, Thorgeirsson G, Sigfusson N.
Predictive value of apolipoproteins in a prospective
survey of coronary artery disease in men. Am J
Cardiol 1992; 69: 1251-4.
25. Rosenberg L, Palmer JR, Shapiro S. Decline in the
risk of myocardial infarction among women who stop
smoking. N Engl J Med 1990; 322: 213-21.
26. Medical Research Council Working Party: MRC trial
of treatment of mild hypertension: principal results.
Br Med J 1985; 292: 97-104.
27. Kannet WB, Dawber TR, McGee DL. Perspectives
on systolic hypertension. The Framingham study.
Circulation 1986; 61: 1179-1182.
28. Zanchetti A. Diastolic, systolic and 24 hour blood
pressure: Which should be treated? Intemational
Society of Hypertension 1988, Hypertension Annual;
1988: 3-19.
29. Holme I. Drug treatment of mild hypertension to
reduce the risk of CHD: Is it worth-while? Stat Med
1988; 7: 1109-20.